- Home
- LVTX vs IOTR Comparison
LVTX vs IOTR Comparison
Compare LVTX & IOTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVTX
- IOTR
- Stock Information
- Founded
- LVTX 2016
- IOTR 2019
- Country
- LVTX Netherlands
- IOTR Singapore
- Employees
- LVTX N/A
- IOTR N/A
- Industry
- LVTX Biotechnology: Pharmaceutical Preparations
- IOTR
- Sector
- LVTX Health Care
- IOTR
- Exchange
- LVTX Nasdaq
- IOTR NYSE
- Market Cap
- LVTX 33.1M
- IOTR 29.5M
- IPO Year
- LVTX 2021
- IOTR 2025
- Fundamental
- Price
- LVTX $1.29
- IOTR $0.45
- Analyst Decision
- LVTX Hold
- IOTR
- Analyst Count
- LVTX 3
- IOTR 0
- Target Price
- LVTX $1.75
- IOTR N/A
- AVG Volume (30 Days)
- LVTX 50.0K
- IOTR 615.4K
- Earning Date
- LVTX 05-14-2025
- IOTR 01-01-0001
- Dividend Yield
- LVTX N/A
- IOTR N/A
- EPS Growth
- LVTX N/A
- IOTR N/A
- EPS
- LVTX N/A
- IOTR N/A
- Revenue
- LVTX $4,990,000.00
- IOTR $9,578,336.00
- Revenue This Year
- LVTX N/A
- IOTR N/A
- Revenue Next Year
- LVTX N/A
- IOTR N/A
- P/E Ratio
- LVTX N/A
- IOTR N/A
- Revenue Growth
- LVTX N/A
- IOTR 13.93
- 52 Week Low
- LVTX $0.85
- IOTR $0.31
- 52 Week High
- LVTX $2.53
- IOTR $5.98
- Technical
- Relative Strength Index (RSI)
- LVTX 51.81
- IOTR N/A
- Support Level
- LVTX $1.18
- IOTR N/A
- Resistance Level
- LVTX $1.34
- IOTR N/A
- Average True Range (ATR)
- LVTX 0.08
- IOTR 0.00
- MACD
- LVTX 0.00
- IOTR 0.00
- Stochastic Oscillator
- LVTX 68.75
- IOTR 0.00
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.